Malignant Central Nervous System Neoplasm

Malignant Central Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,864 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 822
Recruiting: 449
Ph III recruiting: 27
Growth YoY: +21.1%
Industry share: 16%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%
Trials / 1,000 deaths: 45.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (419)

clinicaltrialsPublishedShowing 101–118 of 118 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04747145	Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma	active not recruiting	Phase 2	38	Medical College of WisconsinOTHER	1	Aug 21, 2025	clinicaltrials
NCT04910022	Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma	active not recruiting	Phase 1 / Phase 2	150	Nerviano Medical SciencesINDUSTRY	5	Aug 19, 2025	clinicaltrials